Cellectis SA (CLLS)
1.87
+0.01
(+0.54%)
USD |
NASDAQ |
Nov 22, 16:00
1.88
+0.01
(+0.53%)
After-Hours: 20:00
Cellectis Free Cash Flow: 60.38M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | 60.38M |
| June 30, 2024 | 51.25M |
| March 31, 2024 | -20.85M |
| December 31, 2023 | -25.82M |
| September 30, 2023 | -66.74M |
| June 30, 2023 | -77.66M |
| March 31, 2023 | -81.19M |
| December 31, 2022 | -89.88M |
| September 30, 2022 | -108.91M |
| June 30, 2022 | -118.12M |
| March 31, 2022 | -111.21M |
| December 31, 2021 | -123.12M |
| September 30, 2021 | -152.66M |
| June 30, 2021 | -148.70M |
| March 31, 2021 | -167.33M |
| December 31, 2020 | -124.68M |
| September 30, 2020 | -80.17M |
| June 30, 2020 | -76.34M |
| Date | Value |
|---|---|
| March 31, 2020 | -64.38M |
| December 31, 2019 | -82.10M |
| September 30, 2019 | -99.64M |
| June 30, 2019 | -87.77M |
| March 31, 2019 | -76.62M |
| December 31, 2018 | -73.02M |
| September 30, 2018 | -59.99M |
| June 30, 2018 | -60.00M |
| March 31, 2018 | -58.77M |
| December 31, 2017 | -54.98M |
| September 30, 2017 | -44.42M |
| June 30, 2017 | -32.54M |
| March 31, 2017 | -33.56M |
| December 31, 2016 | -46.74M |
| September 30, 2016 | -19.59M |
| June 30, 2016 | -20.68M |
| March 31, 2016 | -26.53M |
| December 31, 2015 | -0.822M |
Free Cash Flow Range, Past 5 Years
-167.33M
Minimum
Mar 2021
60.38M
Maximum
Sep 2024
-80.41M
Average
-81.64M
Median
Free Cash Flow Benchmarks
| Edap TMS SA | -24.95M |
| Genfit SA | -- |
| DBV Technologies SA | -108.72M |
| Akari Therapeutics PLC | -14.84M |
| Biodexa Pharmaceuticals PLC | -11.12M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -5.829M |
| Cash from Investing (Quarterly) | 22.33M |
| Cash from Financing (Quarterly) | -4.218M |
| Free Cash Flow Per Share (Quarterly) | -0.0663 |
| Free Cash Flow to Equity (Quarterly) | -8.455M |
| Free Cash Flow to Firm (Quarterly) | -6.634M |
| Free Cash Flow Yield | 36.04% |